сряда, 30 септември 2020 г.

Weekly Update: New diabetes clinical trial (14 items)


New diabetes clinical trial: Eating Disorders in Type 1 Insulin-dependent Diabetes Patients

Published on: August 10, 2020 at 07:00PM
Conditions:   Type 1 Diabetes;   Eating Disorders
Intervention:   Other: cohort
Sponsors:   Icadom;   AGIR à Dom
Recruiting
https://clinicaltrials.gov/ct2/show/NCT04506216?term=diabetes&sfpd_d=14 August 10, 2020 at 04:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Sleep Optimization to Improve Glycemic Control in Adults With Type 1 Diabetes

Published on: August 10, 2020 at 07:00PM
Condition:   Type 1 Diabetes
Interventions:   Behavioral: Sleep-Opt;   Behavioral: Healthy Living
Sponsors:   University of Illinois at Chicago;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04506151?term=diabetes&sfpd_d=14 August 10, 2020 at 04:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Efficacy and Safety of TRC041266 in Patients With Heart Failure, LVEF ≥40%, Diastolic Dysfunction and Type 2 Diabetes Mellitus

Published on: August 11, 2020 at 07:00PM
Condition:   Chronic Stable Heart Failure
Interventions:   Drug: TRC041266;   Drug: Placebo
Sponsor:   Torrent Pharmaceuticals Limited
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04507347?term=diabetes&sfpd_d=14 August 11, 2020 at 02:24PM

via ClinicalTrials.gov


New diabetes clinical trial: The Effect of Donepezil on Glycemic Control in Type II Diabetics

Published on: August 11, 2020 at 07:00PM
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Donepezil 5-10 Mg Oral Tablet;   Drug: Placebo Oral Tablet
Sponsor:   University of Maryland, Baltimore
Recruiting
https://clinicaltrials.gov/ct2/show/NCT04507438?term=diabetes&sfpd_d=14 August 11, 2020 at 02:24PM

via ClinicalTrials.gov


New diabetes clinical trial: A Study Using Electronic Health Information to Learn About Rivaroxaban Compared to Warfarin in Participants With Non-valvular Atrial Fibrillation (NVAF) and Diabetes

Published on: August 11, 2020 at 07:00PM
Condition:   Atrial Fibrillation
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Warfarin
Sponsors:   Bayer;   Janssen Research and Development LLC
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04509193?term=diabetes&sfpd_d=14 August 11, 2020 at 02:24PM

via ClinicalTrials.gov


New diabetes clinical trial: MELD-ATG: Phase II, Dose Ranging, Efficacy Study of Anti-thymocyte Globulin (ATG) Within 6 Weeks of Diagnosis of Type 1 Diabetes (T1D)

Published on: August 12, 2020 at 07:00PM
Condition:   Diabetes Mellitus, Type 1
Intervention:   Drug: Anti-Human Thymocyte Immunoglobulin, Rabbit
Sponsor:   Universitaire Ziekenhuizen Leuven
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04509791?term=diabetes&sfpd_d=14 August 12, 2020 at 02:24PM

via ClinicalTrials.gov


New diabetes clinical trial: An 8-Day Initiation of Advanced Hybrid Closed Loop System In Children and Adolescents

Published on: August 12, 2020 at 07:00PM
Condition:   Type 1 Diabetes
Intervention:   Device: Advanced Hybrid Closed Loop System
Sponsor:   Sidra Medical and Research Center
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04509362?term=diabetes&sfpd_d=14 August 12, 2020 at 02:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Artificial Pancreas - Adolescent Physiology & Psychology Longitudinal Evaluation

Published on: August 12, 2020 at 07:00PM
Condition:   Type 1 Diabetes
Intervention:   Device: Artificial Pancreas (AP)
Sponsors:   University of Virginia;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   DexCom, Inc.;   Tandem Diabetes Care, Inc.
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04510506?term=diabetes&sfpd_d=14 August 12, 2020 at 02:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Canakinumab in Patients With COVID-19 and Type 2 Diabetes

Published on: August 12, 2020 at 07:00PM
Conditions:   Coronavirus Infection;   Diabetes Mellitus, Type 2
Interventions:   Drug: Canakinumab;   Drug: Placebo
Sponsors:   University Hospital, Basel, Switzerland;   Novartis;   Swiss National Science Foundation
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04510493?term=diabetes&sfpd_d=14 August 12, 2020 at 02:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Teach-Back Educational Method On Diabetes Knowledge Level

Published on: August 12, 2020 at 07:00PM
Condition:   Patient Empowerment
Intervention:   Behavioral: Teach-back educational method
Sponsor:   Ataturk University
Completed
https://clinicaltrials.gov/ct2/show/NCT04509856?term=diabetes&sfpd_d=14 August 12, 2020 at 02:24PM

via ClinicalTrials.gov


New diabetes clinical trial: The Effects of a Novel Lifestyle Intervention Program on Insulin Sensitivity in Type 2 Diabetes

Published on: August 12, 2020 at 07:00PM
Conditions:   Type 2 Diabetes;   Fatty Liver, Nonalcoholic
Intervention:   Behavioral: Low-calorie diet supported by an app-guided digital education program, nutritional coaching calls via phone
Sponsor:   German Diabetes Center
Completed
https://clinicaltrials.gov/ct2/show/NCT04509245?term=diabetes&sfpd_d=14 August 12, 2020 at 02:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Effects of White Potato Consumption on Measures of Cardiometabolic Health in Individuals With Type 2 Diabetes Mellitus

Published on: August 13, 2020 at 07:00PM
Conditions:   Type2 Diabetes;   Cardiometabolic Syndrome;   Arterial Stiffness;   Overweight and Obesity
Interventions:   Other: Potato Regimen;   Other: Refined Grain Regimen
Sponsors:   Florida State University;   Alliance for Potato Research and Education
Recruiting
https://clinicaltrials.gov/ct2/show/NCT04511325?term=diabetes&sfpd_d=14 August 13, 2020 at 02:24PM

via ClinicalTrials.gov


New diabetes clinical trial: NEW ONSET ENDOCRINE DYSFUNCTION AFTER ACUTE PANCREATITIS

Published on: August 14, 2020 at 07:00PM
Condition:   Endocrine System Diseases
Intervention:  
Sponsor:   Asian Institute of Gastroenterology, India
Recruiting
https://clinicaltrials.gov/ct2/show/NCT04513197?term=diabetes&sfpd_d=14 August 14, 2020 at 03:24PM

via ClinicalTrials.gov


New diabetes clinical trial: MyFIT : Acceptability Study

Published on: August 14, 2020 at 07:00PM
Condition:   Type1diabetes
Intervention:   Other: Survey
Sponsor:   Central Hospital, Nancy, France
Recruiting
https://clinicaltrials.gov/ct2/show/NCT04512885?term=diabetes&sfpd_d=14 August 14, 2020 at 03:24PM

via ClinicalTrials.gov


Няма коментари:

Публикуване на коментар